megestrol has been researched along with Neoplasm Metastasis in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (66.00) | 18.7374 |
| 1990's | 15 (30.00) | 18.2507 |
| 2000's | 2 (4.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumenschein, GR; Buzdar, AU; Ross, MB | 1 |
| Adlercreutz, H; Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Docter, R; Hop, WC; Klijn, JG; Lamberts, SW; van Gilse, HA | 1 |
| Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Lamberts, SW | 1 |
| Bukowski, RM; James, RE; Montie, JE; Stewart, BH; Straffon, RA | 1 |
| Anderson, K; Block, M; Bonomi, P; Pessis, D; Showel, J; Slayton, R; Wolter, J | 1 |
| Major, FJ; Moore, GE; Myers, AM | 1 |
| Alexieva-Figusch, J; Blonk-van der Wijst, J; Hop, WC; Phoa, CH; Treurniet, RE; van Gilse, HA | 1 |
| Dawson, NA; McLeod, DG | 1 |
| Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D | 1 |
| Abulafia, O; Sherer, DM | 1 |
| Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
| Burns, I; Byrne, M; Coates, A; Gebski, V; Gill, PG; Levi, J; Snyder, R | 1 |
| Cobau, CD; Declercq, K; Ingle, JN; Neuberg, D; Tormey, DC | 1 |
| Gebbia, N; Gebbia, V; Testa, A | 1 |
| Bianco, AR; Carlomagno, C; De Placido, S; Lauria, R; Morabito, A; Perrone, F | 1 |
| Costello, S; Glück, S; Heffernan, M; Hortobagyi, GN; Kennedy, I; Knight, RD; Leff, R; Lipton, A; Mellars, K; Reitsma, DJ; Seaman, JJ; Simeone, J; Stewart, JF; Theriault, RL | 1 |
| Cattel, F; Messori, A; Trippoli, S; Vaiani, M | 1 |
| Davis, TE; Erban, JK; Krook, JE; Pandya, KJ; Schinella, RA; Weiner, LM; Yeap, BY | 1 |
| Bauer, M; Bennett, JM; Creech, R; Hahn, RG; Wampler, G; Wolter, J | 1 |
| Bellet, RE; Koons, LS; Laucius, JF; Lusch, CJ; Mastrangelo, MJ; Patel, YA | 1 |
| Blumenschein, GR; Bodey, GP; Buzdar, AU; Hortobagyi, GN; Krutchik, AN; Livingston, RB; Tashima, CK; Yap, HY | 1 |
| Ansfield, FJ; Borden, EC; Bryan, GT; Davis, HL; Davis, TE; Johnson, RO; Ramirez, G | 1 |
| Ayala, AG; Johnson, DE; Kaesler, KE | 1 |
| Cruz, JM; Muss, HB | 1 |
| Venner, P | 1 |
| Cruz, JM; Muss, HB; Russell, G | 1 |
| Abrams, JS; Aisner, J; Parnes, HL; Tait, N; Tchekmedyian, NS | 1 |
| Brenner, BG; Margolese, RG | 1 |
| Brockschmidt, JK; Cruz, JM; Evans, GW; Muss, HB | 1 |
| Gundersen, S; Klepp, R; Kvinnsland, S; Lund, E; Lundgren, S; Lønning, PE | 1 |
| Albert, JD; Geller, J | 1 |
| Soloway, MS | 1 |
| Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE | 1 |
| Becher, R; Miller, AA; Schmidt, CG | 1 |
| Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC | 1 |
| Blossey, HC; Emrich, D; Nagel, GA; Wander, HE | 1 |
| Glick, JH; Haller, DG | 1 |
| Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Powell, BL; Wells, HB | 1 |
| Abrams, J; Aisner, J; Tait, N; Tchekmedyian, NS | 1 |
| Gale, KE; Hahn, RG; Horton, J; Keller, AM; Knuiman, M; Rosenbluth, RJ; Tormey, DC; Vogel, H | 1 |
| Allegra, JC | 1 |
| Crombie, C; Dalley, D; Devine, R; Page, J; Raghavan, D; Rosen, M; Woods, R | 1 |
| Allegra, JC; Bertino, J; Bonomi, P; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Durivage, H; Einhorn, L | 1 |
| Alexieva-Figusch, J; Blonk-vd Wijst, J; Klijn, JG; van Gilse, HA; Van Putten, WL | 1 |
| Wait, RB | 1 |
| Rozier, JC; Underwood, PB | 1 |
| Murnaghan, GF | 1 |
| van der Werf-Messing, B; van Gilse, HA | 1 |
5 review(s) available for megestrol and Neoplasm Metastasis
| Article | Year |
|---|---|
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Neoplasm Metastasis; Pleural Effusion, Malignant | 1995 |
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol; Neoplasm Metastasis; Nitriles; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2000 |
High-dose progestin therapy for metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Megestrol; Megestrol Acetate; Neoplasm Metastasis | 1992 |
Megestrol acetate in the treatment of metastatic carcinoma of the prostate.
Topics: Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prostatic Neoplasms | 1992 |
Adrenal androgen blockade in relapsed prostate cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Castration; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Prostate; Prostatic Neoplasms | 1985 |
17 trial(s) available for megestrol and Neoplasm Metastasis
| Article | Year |
|---|---|
Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.
Topics: Administration, Oral; Aged; Blood Glucose; Breast Neoplasms; Cortodoxone; Drug Administration Schedule; Estradiol; Female; Humans; Insulin; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin | 1984 |
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Survival Rate; Tamoxifen | 1993 |
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Survival Rate | 1996 |
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Topics: Aged; Anorexia; Appetite; Body Weight; Cachexia; Dose-Response Relationship, Drug; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms; Prospective Studies; Syndrome | 1996 |
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Megestrol; Middle Aged; Neoplasm Metastasis; Pamidronate; Tamoxifen | 1999 |
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Megestrol; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proportional Hazards Models; Survival Rate; Tamoxifen | 2001 |
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Drug Evaluation; Etoposide; Humans; Kidney Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Sugar Alcohols | 1979 |
High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis | 1992 |
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Male; Megestrol; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 1991 |
Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
Topics: Blood Pressure; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Weight Gain | 1990 |
Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation | 1987 |
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Breast Neoplasms; Female; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Receptors, Cell Surface; Testosterone | 1985 |
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission Induction; Tamoxifen | 1988 |
Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1987 |
Metastatic breast cancer: preliminary results with oral hormonal therapy.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1985 |
28 other study(ies) available for megestrol and Neoplasm Metastasis
| Article | Year |
|---|---|
Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Tamoxifen | 1982 |
Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Sex Hormone-Binding Globulin; Tamoxifen; Thyrotropin-Releasing Hormone | 1984 |
A critical review of immunotherapy of disseminated renal adenocarcinoma.
Topics: Adenocarcinoma; BCG Vaccine; Drug Evaluation; Drug Therapy, Combination; Humans; Kidney Neoplasms; Lomustine; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Nitrosourea Compounds; Transfer Factor | 1982 |
Treatment of stage D prostatic carcinoma with megestrol acetate.
Topics: Aged; Humans; Male; Megestrol; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms | 1981 |
Advanced ovarian carcinoma: response to antiestrogen therapy.
Topics: Adult; Cystadenocarcinoma; Estrogen Antagonists; Female; Humans; Megestrol; Middle Aged; Nafoxidine; Neoplasm Metastasis; Ovarian Neoplasms; Tamoxifen | 1981 |
Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases.
Topics: Age Factors; Aged; Body Weight; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Lung Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Progesterone Congeners; Remission, Spontaneous; Retrospective Studies; Soft Tissue Neoplasms | 1980 |
Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
Topics: Aged; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome | 1995 |
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53 | 1995 |
Recurrent transient superior vena cava-like syndrome possibly associated with megestrol acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Hysterectomy; Megestrol; Neoplasm Metastasis; Neoplasm Staging; Ovariectomy; Recurrence; Superior Vena Cava Syndrome | 1995 |
The phase II evaluation of Bacillus Calmette-Guerin plus megestrol acetate in patients with metastatic renal adenocarcinoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; BCG Vaccine; Drug Evaluation; Evaluation Studies as Topic; Female; Humans; Immunoglobulins; Injections, Intradermal; Kidney Neoplasms; Lung Neoplasms; Male; Megestrol; Middle Aged; Neoplasm Metastasis; Skin Tests | 1977 |
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy.
Topics: Adult; Aged; Bone Marrow; Breast Neoplasms; Drug Resistance; Drug Therapy, Combination; Female; Humans; Megestrol; Middle Aged; Mitomycins; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1978 |
Further clinical studies with megestrol acetate in advanced breast cancer.
Topics: Breast Neoplasms; Drug Evaluation; Female; Humans; Male; Megestrol; Menopause; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1976 |
Megestrol acetate for treatment of advanced carcinoma of the prostate.
Topics: Administration, Oral; Aged; Humans; Male; Megestrol; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms | 1975 |
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxicity, Immunologic; Humans; Immunity, Innate; Killer Cells, Natural; Leukocyte Count; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasm Staging; Tamoxifen | 1991 |
[Palliative treatment of skeletal metastases in patients with breast carcinoma].
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Megestrol; Neoplasm Metastasis; Palliative Care | 1987 |
Combined treatment with flutamide and surgical or medical (LHRH agonist) castration in metastatic prostatic cancer.
Topics: Anilides; Combined Modality Therapy; Cyproterone; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Receptors, Cell Surface; Receptors, LHRH | 1986 |
Treatment of prostatic cancer. Newer forms of androgen deprivation.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1986 |
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay | 1988 |
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
High-dose megestrol acetate in the treatment of advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis | 1988 |
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1987 |
Phase II study of megestrol acetate for metastatic carcinoma of the prostate.
Topics: Aged; Humans; Liver; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms | 1987 |
Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Topics: Administration, Oral; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Tamoxifen | 1985 |
Megestrol acetate in the management of advanced endometrial carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Antineoplastic Agents; Drug Synergism; Endometrium; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Neoplasms; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms | 1973 |
Use of progestational agents in endometrial adenocarcinoma.
Topics: Adenocarcinoma; Administration, Oral; Endometrium; Female; Humans; Injections, Intramuscular; Medrogestone; Medroxyprogesterone; Megestrol; Neoplasm Metastasis; Neoplasm Recurrence, Local; Progestins; Uterine Neoplasms | 1974 |
Endocrine aspects of renal carcinoma.
Topics: Adult; Aged; Ethynodiol Diacetate; Female; Humans; Kidney Neoplasms; Male; Megestrol; Middle Aged; Neoplasm Metastasis; Nephrectomy; Testosterone | 1972 |
Hormonal treatment of metastases of renal carcinoma.
Topics: Age Factors; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Megestrol; Middle Aged; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Nephrectomy; Progesterone; Progestins; Prognosis; Sex Factors; Testosterone | 1971 |